• Home

  • Documents

  • phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date:...
35

phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM

  • Upload
    vukhue

  • View
    216

  • Download
    0

Embed Size (px)

Citation preview

Page 1: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 2: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 3: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 4: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 5: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 6: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 7: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 8: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 9: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 10: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 11: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 12: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 13: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 14: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 15: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 16: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 17: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 18: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 19: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 20: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 21: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 22: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 23: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 24: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 25: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 26: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 27: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 28: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 29: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 30: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 31: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 32: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 33: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 34: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM
Page 35: phoenix.tuwien.ac.atphoenix.tuwien.ac.at/lectures/pharma/MedChem_Kapitel_22.pdf · Created Date: 5/14/2008 1:53:14 PM

“Aurobindo Pharma Limited’s Q3 FY2013-14 Unaudited ... · “Aurobindo Pharma Limited’s Q3 FY2013-14 Unaudited Earnings Conference Call” February 7, 2014 MANAGEMENT: ... Pharma

“Aurobindo Pharma Limited’s Q3 FY2013-14 Unaudited ... · “Aurobindo Pharma Limited’s Q3 FY2013-14 Unaudited Earnings Conference Call” February 7, 2014 MANAGEMENT: ... Pharma

Documents
“Chemical Engineering Equilibrium Separations” Lectures 14

“Chemical Engineering Equilibrium Separations” Lectures 14

Documents
Mint Bangalore 11-11-14 - Intas Pharma · INTAS Expressions for a Healthy Life Pharma Co Intas completes Sale of ChrysCapital's Stake to Temasek Our Bureau Ahmedabad: Intas Pharma-

Mint Bangalore 11-11-14 - Intas Pharma · INTAS Expressions for a Healthy Life Pharma Co Intas completes Sale of ChrysCapital's Stake to Temasek Our Bureau Ahmedabad: Intas Pharma-

Documents
Qcl 14-v3 [bunking lectures]-[banasthaliuniversity]_[garimasrivastava]

Qcl 14-v3 [bunking lectures]-[banasthaliuniversity]_[garimasrivastava]

Education
Lectures 11 to 14 ns 5 2010

Lectures 11 to 14 ns 5 2010

Documents
Lectures 14-15: Deontological & Consequential Ethics

Lectures 14-15: Deontological & Consequential Ethics

Documents
2020 Media Kit - For Pharma Industry Executives€¦ · 01/09/2018  · Pharma traceability: Beyond the barcode. JUN. 2019 VOL. 14 NO. 2. Pharma cold chain: greener and more digitized

2020 Media Kit - For Pharma Industry Executives€¦ · 01/09/2018  · Pharma traceability: Beyond the barcode. JUN. 2019 VOL. 14 NO. 2. Pharma cold chain: greener and more digitized

Documents
The Blurring Line Between Discovery, Pharmacology, and ...phoenix.tuwien.ac.at/lectures/pharma/LastLecture.pdf · The Blurring Line Between Discovery, Pharmacology, and Preclinics

The Blurring Line Between Discovery, Pharmacology, and ...phoenix.tuwien.ac.at/lectures/pharma/LastLecture.pdf · The Blurring Line Between Discovery, Pharmacology, and Preclinics

Documents
Carewell Pharma Carewell Pharma Carewell Pharma Carewell

Carewell Pharma Carewell Pharma Carewell Pharma Carewell

Documents
Chemistry 1B-AL, Fall 2016 Lectures 13-14 1B-AL, Fall 2016 Lectures 13-14 1 1 Chemistry 1B Fall 2016 Topics Lectures 13-14 Quantum Mechanics of the Covalent Bond ... no node ADD SUBTRACT

Chemistry 1B-AL, Fall 2016 Lectures 13-14 1B-AL, Fall 2016 Lectures 13-14 1 1 Chemistry 1B Fall 2016 Topics Lectures 13-14 Quantum Mechanics of the Covalent Bond ... no node ADD SUBTRACT

Documents
ACONWELL PHARMA PVT. LTD. › assets › catalogue › ...ACONWELL PHARMA PVT. LTD. Company Address: 1st Floor, Khasra No-8/14/14 Arjun Nagar, Ambala Cantt, Haryana-133001 Email Id:

ACONWELL PHARMA PVT. LTD. › assets › catalogue › ...ACONWELL PHARMA PVT. LTD. Company Address: 1st Floor, Khasra No-8/14/14 Arjun Nagar, Ambala Cantt, Haryana-133001 Email Id:

Documents
Digitalization in Pharma · 2018-02-14 · Page 10 24 July 2017 Business Segment Pharma, Howard Sachs A holistic approach in the Pharma Industry Specific for process and discrete

Digitalization in Pharma · 2018-02-14 · Page 10 24 July 2017 Business Segment Pharma, Howard Sachs A holistic approach in the Pharma Industry Specific for process and discrete

Documents
5/14/2020 - Hyphens Pharma International Ltd · 5/14/2020  · 5/14/2020 1 HYPHENS PHARMA INTL LTD (SGX: 1J5) Hyphens Pharma International Limited Results Briefing 1Q2020 DISCLAIMER

5/14/2020 - Hyphens Pharma International Ltd · 5/14/2020  · 5/14/2020 1 HYPHENS PHARMA INTL LTD (SGX: 1J5) Hyphens Pharma International Limited Results Briefing 1Q2020 DISCLAIMER

Documents
Pharma Tentative · Email: Pharma@hazlegroup.org Contact: +1-216-929-4565 Bookmark Your dates from 14-15, 2021 CPD 2021 . Title: Pharma Tentative Author: muraliratnapuri …

Pharma Tentative · Email: [email protected] Contact: +1-216-929-4565 Bookmark Your dates from 14-15, 2021 CPD 2021 . Title: Pharma Tentative Author: muraliratnapuri …

Documents
14 January 2021 Sector Update Pharma - Ample catalysts... · 2021. 1. 14. · Pharma HSIE Research is also available on Bloomberg ERH HDF & Thomson Reuters Ample catalysts

14 January 2021 Sector Update Pharma - Ample catalysts... · 2021. 1. 14. · Pharma HSIE Research is also available on Bloomberg ERH HDF & Thomson Reuters Ample catalysts

Documents
JWC 3PL Pharma 24 12 14(Customer)

JWC 3PL Pharma 24 12 14(Customer)

Documents
Phys101 Lectures 13, 14 - SFU.camxchen/phys1011101/Lecture13B.pdfPhys101 Lectures 13, 14 Momentum and Collisions Key points: •Momentum and impulse •Condition for conservation of

Phys101 Lectures 13, 14 - SFU.camxchen/phys1011101/Lecture13B.pdfPhys101 Lectures 13, 14 Momentum and Collisions Key points: •Momentum and impulse •Condition for conservation of

Documents
Lectures in Applied Econometrics 14

Lectures in Applied Econometrics 14

Documents
ONLINE #PMC2020 12 - 13, 2020 Pharma Microbiology Congress … · 2020. 9. 14. · PLENARY SESSION 12 Technical speeches 10 Q&A time 8 Multimedial contents 5 Round tables 2 Lectures

ONLINE #PMC2020 12 - 13, 2020 Pharma Microbiology Congress … · 2020. 9. 14. · PLENARY SESSION 12 Technical speeches 10 Q&A time 8 Multimedial contents 5 Round tables 2 Lectures

Documents
2-Lectures LEC 14

2-Lectures LEC 14

Documents
Social Choice Lectures 14 and 15

Social Choice Lectures 14 and 15

Documents
Crowdopolis 14-slides-alph-bingham inno centive pharma

Crowdopolis 14-slides-alph-bingham inno centive pharma

Marketing
14.AROMATIC COMPOUNDS. ( approx. lecture time: 2 lectures)

14.AROMATIC COMPOUNDS. ( approx. lecture time: 2 lectures)

Documents
PharmaNews - Accenture · 12/14/2015  · Pharma Industry and the implications for Pharma Companies. Our first article explores Pharma Companies’ interest in patient services and

PharmaNews - Accenture · 12/14/2015  · Pharma Industry and the implications for Pharma Companies. Our first article explores Pharma Companies’ interest in patient services and

Documents
Welding lectures 14 16

Welding lectures 14 16

Engineering
Ecology: Lectures 14-16

Ecology: Lectures 14-16

Documents
Sustainable Pharma · 2018. 2. 14. · Slide 1 © PharmOut 2017 Sustainable Pharma Presented by Nic van der Nol, July 2017

Sustainable Pharma · 2018. 2. 14. · Slide 1 © PharmOut 2017 Sustainable Pharma Presented by Nic van der Nol, July 2017

Documents
GROWTH - SUN Pharma SPIL- Annual... · our focus on growth remains ... Brazil 11-14 Russia 9-12 India 11-14 Tier 3 7-10 Pharmerging 11-14 Table 1 Global Pharma Market Growth Rate

GROWTH - SUN Pharma SPIL- Annual... · our focus on growth remains ... Brazil 11-14 Russia 9-12 India 11-14 Tier 3 7-10 Pharmerging 11-14 Table 1 Global Pharma Market Growth Rate

Documents
Chapter 14: Social Psychology Lectures 20, 21, & 22

Chapter 14: Social Psychology Lectures 20, 21, & 22

Documents
MGT3121 - Lectures 14 & 15 - Globalization(1)

MGT3121 - Lectures 14 & 15 - Globalization(1)

Documents